Evolent Health Inc Class A (EVH)
NYSE: EVHHealthcareHealth Information ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
EVH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $468.07M
- Forward P/E
- 10.25
- EPS (TTM)
- -$4.49
- Dividend yield
- None
- 52-week range
- 2.10 – 8.34
- Day range
- 3.78 – 4.18
- Volume / Avg
- 2.80M / 2.97M
- Beta
- —
- Shares outstanding
- 113.06M
- Next earnings
- Nov 5, 2026
52-week range
EVH stock today
Shares of Evolent Health (EVH) finished higher on Oct 7 at $4.14, a gain of 7.81% or $0.30 per share, versus the S&P 500's 0.22% decline. Shares are 50.3% below their 52-week high of $8.34 and 97.6% above the 52-week low of $2.10, in the middle of the past year's range. EVH is up 3.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 49.0%.
Evolent Health has posted a net loss over the last twelve months (EPS of -$4.49), so its P/E ratio is not meaningful. Evolent Health's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Evolent Health
Company profileEvolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. Seth Barrie Blackley
- Headquarters
- Arlington, VA
- Employees
- 4,200
- IPO year
- 2015
- Website
- evolent.com
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$5.75+38.89%
- Strong buy 4
- Buy 7
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.05
Evolent Health peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NRCNRC Health | 20.19 | +0.55% | $446.59M | vs EVH |
| CTEVClaritev Corporation Class A | 25.03 | +3.90% | $424.20M | vs EVH |
| CARLCarlsmed Inc. | 14.38 | -1.78% | $392.61M | vs EVH |
| WEAVWeave Communications Inc. | 7.37 | -0.14% | $592.92M | vs EVH |
| SOPHSOPHiA GENETICS SA | 7.15 | -3.12% | $608.66M | vs EVH |
| PHRPhreesia Inc. | 10.50 | +2.44% | $651.74M | vs EVH |
| SYSo-Young International Inc. American Depository Shares | 2.55 | -0.78% | $256.57M | vs EVH |
| SPOKSpok Holdings Inc. | 11.05 | +0.82% | $231.15M | vs EVH |
Indexes, lists and sector
Appears in lists
Evolent Health stock FAQ
What is Evolent Health's stock price today?
EVH last traded at $4.14 as of Oct 7, 4:00 PM EDT, up 7.81% on the day. Prices are delayed at least 15 minutes.
When is Evolent Health's next earnings date?
Evolent Health is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.05.
Who is Evolent Health's CEO?
Mr. Seth Barrie Blackley is the chief executive officer of Evolent Health Inc Class A, which has about 4,200 employees.
What is the EVH 52-week high?
The 52-week high for EVH is $8.34 and the 52-week low is $2.10. The stock is currently 50.3% below its high.